Reuters Health Report

Click to View in Browser 03/20/2014 Poor diagnosis driving global multidrug-resistant TB, WHO warns LONDON (Reuters) - Half a million people fell sick with dangerous superbug strains of tuberculosis (TB) in 2012, but fewer than one in four were diagnosed, putting the rest at risk of dying due to the wrong medicines or no treatment at all. GSK cancer vaccine fails again but testing continues (Reuters) - An experimental cancer vaccine from GlaxoSmithKline has failed in a second test - this time against lung cancer - but the British company said it still hoped to identify a sub-group of patients in which it would work. Spankings tied to likelihood of child protective service visits NEW YORK (Reuters Health) - Parents who spank their babies are at greater risk of eventually having Child Protective Services called in to protect their kids than parents who do not spank, according to a new study. Novartis CEO reshapes drugmaker for 'brutal' new world BASEL, Switzerland (Reuters) - Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new era in healthcare spending. Alk expects to launch new allergy tablet in U.S. in 2017 COPENHAGEN (Reuters) - Danish pharmaceutical group Alk Abello expects to start selling its new dust mite allergy tablet in Europe and Japan around the end 2015 with the U.S. market a further year behind, its Chief Executive told Reuters on Thursday. Geron says FDA halts patient enrollment in another cancer trial (Reuters) - Geron Corp said the U.S. Food and Drug Administration ordered a halt to new patient enrollments in an early-stage trial of its blood cancer drug, imetelstat, over concerns about liver damage. Indian quality woes point to generic drugs shake-out: Novartis BASEL, Switzerland (Reuters) - Recent manufacturing problems in India suggest some makers of generic drugs will struggle to compete in the face of a rising quality bar, pointing to a likely a shake-out in the low-cost sector, according to Novartis. You're not alone: Medical conspiracies believed by many NEW YORK (Reuters Health) - About half of American adults believe in at least one medical conspiracy theory, according to new survey results. New heart guidelines may put 12.8 million more Americans on statins CHICAGO (Reuters) - New guidelines on heart health that sparked fierce debate among U.S. cardiologists last fall could lead 12.8 million more Americans to take cholesterol-lowering statin drugs, U.S. researchers said on Wednesday. South Carolina lawmakers advance 20-week abortion ban CHARLESTON, South Carolina (Reuters) - South Carolina's Republican-controlled House of Representatives approved a bill on Wednesday that would ban most abortions after 20 weeks of pregnancy, moving the state closer to becoming the latest to limit access to the procedure. Related Video Old batteries power new lights in Gaza US biologist creates buzz about bees The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend